Copyright © 2013 Knight Sac Media. All rights reserved.http://www.siliconinvestor.com/subject.aspx?subjectid=53529CombiMatrix stock is intended to reflect the performance of Acacia Research's subsidiary, CombiMatrix Corporation. The Acacia Research -- CombiMatrix stock is a class of common stock of Acacia Research and is not a separately issued stock. The CombiMatrix group, consisting of its wholly-owned subs...http://www.siliconinvestor.com/images/Logo380x132.pnghttp://www.siliconinvestor.com/subject.aspx?subjectid=5352938013210Paul Lee CombiMatrix Skyrockets After Important Medical Publication CombiMatrix Skyrockets After Important Medical Publication By Bio-Wire Dec 10, 2012 6:47:17 AM PST | 188 View(s) | No Comment(s) - Post a Comment Rating [iframe style="BORDER-BOTTOM: 0px; BORDER-LEFT: 0px; WIDTH: 90px; HEIGHT: 25px; OVERFLOW: hidde...http://www.siliconinvestor.com/readmsg.aspx?msgid=2859665212/11/2012 10:09:09 AMPaul Lee NIH Studies in New England Journal of Medicine Favor Chromosomal Microarray Analysis Over Standard Karyotyping for Genetic Analysis Largest Head-to-Head Studies Comparing the Two Diagnostic Tools; CombiMatrix: Only Publicly-Traded Diagnostic Laboratory Specializing in Microarray Analysis IRVINE, Calif., Dec. 7,...http://www.siliconinvestor.com/readmsg.aspx?msgid=2859005212/7/2012 7:02:10 AMPaul Lee Author of Nationwide, NIH-Sponsored Study Endorses Microarray Testing as Preferred Standard of Care for Pre-Natal Testing 4,400-Patient Study Reveals That Chromosomal Microarray Testing Identifies a Significantly Greater Number of Genetic Disorders Than Standard Karyotyping CombiMatrix Corporation (Nasdaq: ...http://www.siliconinvestor.com/readmsg.aspx?msgid=279452842/13/2012 8:01:25 AM